Reports for DABIGATRAN ETEXILATE
Ingredient
DABIGATRAN ETEXILATE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DABIGATRAN | 150MG | CAPSULE | Resolved | 2020-04-13 | 2021-01-26 | 111898 |
| PRADAXA | 110MG | CAPSULE | Resolved | 2020-01-22 | 2020-02-04 | 104069 |
| PRADAXA | 150MG | CAPSULE | Resolved | 2020-01-02 | 2020-01-09 | 102112 |
| PRADAXA | 150MG | CAPSULE | Resolved | 2019-11-28 | 2019-12-10 | 99980 |
| PRADAXA | 110MG | CAPSULE | Resolved | 2019-11-28 | 2020-01-14 | 99977 |
| PRADAXA | 150MG | CAPSULE | Resolved | 2019-10-03 | 2019-11-22 | 95404 |
| PRADAXA | 75MG | CAPSULE | Resolved | 2019-07-08 | 2019-08-19 | 88835 |
| APO-DABIGATRAN | 110MG | CAPSULE | Resolved | 2019-06-26 | 2022-10-07 | 87509 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PRADAXA | 110MG | CAPSULE | Discontinued | 2017-12-21 | 2017-12-21 | 34114 |
| PRADAXA | 150MG | CAPSULE | Discontinued | 2017-10-19 | 2017-10-19 | 26385 |
Showing 1 to 2 of 2